0.7255
price down icon5.79%   -0.0446
after-market 시간 외 거래: .74 0.0145 +2.00%
loading
전일 마감가:
$0.7701
열려 있는:
$0.7714
하루 거래량:
521.24K
Relative Volume:
0.11
시가총액:
$26.25M
수익:
-
순이익/손실:
$-6.00M
주가수익비율:
-5.4223
EPS:
-0.1338
순현금흐름:
$-31.01M
1주 성능:
-12.83%
1개월 성능:
-26.29%
6개월 성능:
-67.90%
1년 성능:
-83.13%
1일 변동 폭
Value
$0.72
$0.7714
1주일 범위
Value
$0.72
$0.849
52주 변동 폭
Value
$0.4641
$5.97

Briacell Therapeutics Corp Stock (BCTX) Company Profile

Name
명칭
Briacell Therapeutics Corp
Name
전화
(604) 921-1810
Name
주소
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
Name
직원
18
Name
트위터
Name
다음 수익 날짜
2024-10-28
Name
최신 SEC 제출 서류
Name
BCTX's Discussions on Twitter

Briacell Therapeutics Corp Stock (BCTX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2022-02-14 개시 H.C. Wainwright Buy

Briacell Therapeutics Corp 주식(BCTX)의 최신 뉴스

pulisher
Nov 04, 2024

BriaCell Overall Survival Data Selected for Spotlight - GlobeNewswire

Nov 04, 2024
pulisher
Nov 04, 2024

BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium®, December 10 – 13 - StockTitan

Nov 04, 2024
pulisher
Nov 01, 2024

BriaCell Therapeutics Faces Uncertain Financial Future - TipRanks

Nov 01, 2024
pulisher
Oct 28, 2024

BriaCell Therapeutics Corp. Reports Earnings Results for the Full Year Ended July 31, 2024 - Marketscreener.com

Oct 28, 2024
pulisher
Oct 22, 2024

BriaCell Therapeutics: High-Potential In Phase 3 Metastatic Breast Cancer, But Financing Concerns - Seeking Alpha

Oct 22, 2024
pulisher
Oct 22, 2024

BriaCell reports survival data from Phase 2 study | 2024-10-22 | Investing News - Stockhouse Publishing

Oct 22, 2024
pulisher
Oct 22, 2024

BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data - GlobeNewswire

Oct 22, 2024
pulisher
Oct 16, 2024

You might want to take a look at BriaCell Therapeutics Corp (BCTX) now - SETE News

Oct 16, 2024
pulisher
Oct 15, 2024

BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study - GlobeNewswire

Oct 15, 2024
pulisher
Oct 15, 2024

BriaCell Therapeutics advances Phase 3 MBC clinical study | 2024-10-15 | Investing News - Stockhouse Publishing

Oct 15, 2024
pulisher
Oct 15, 2024

BCTX’s 52-Week Rollercoaster: From $0.46 to $5.97 – What’s Next for Investors? - The InvestChronicle

Oct 15, 2024
pulisher
Oct 15, 2024

BriaCell stock gains after trial update (NASDAQ:BCTX) - Seeking Alpha

Oct 15, 2024
pulisher
Oct 15, 2024

Extendicare Inc. - Baystreet.ca

Oct 15, 2024
pulisher
Oct 15, 2024

BriaCell Therapeutics Corp. - Baystreet.ca

Oct 15, 2024
pulisher
Oct 14, 2024

Analyzing BriaCell Therapeutics Corp (BCTX) After Recent Trading Activity - Knox Daily

Oct 14, 2024
pulisher
Oct 14, 2024

BriaCell Therapeutics Corp (BCTX)’s highs and lows: A closer look at its stock price fluctuations - US Post News

Oct 14, 2024
pulisher
Oct 14, 2024

Deeper Dive: Understanding BriaCell Therapeutics Corp (BCTX) Through its Various Ratios - The Dwinnex

Oct 14, 2024
pulisher
Oct 09, 2024

Clean Harbors (CLH-N) QuotePress Release - The Globe and Mail

Oct 09, 2024
pulisher
Oct 08, 2024

BriaCell Therapeutics Corp: Navigating a Turbulent Year, Up -82.63% from 52-Week Low - The InvestChronicle

Oct 08, 2024
pulisher
Oct 08, 2024

Financial Metrics Check: BriaCell Therapeutics Corp (BCTX)’s Ratios for Trailing Twelve Months - The Dwinnex

Oct 08, 2024
pulisher
Oct 08, 2024

It is Poised to be a Bull Market for BriaCell Therapeutics Corp (BCTX) - SETE News

Oct 08, 2024
pulisher
Oct 07, 2024

A Guide To The Risks Of Investing In BriaCell Therapeutics Corp (BCTX) - Knox Daily

Oct 07, 2024
pulisher
Oct 04, 2024

BMO MSCI ACWI Paris Aligned Climate Equi (ZGRN-T) QuotePress Release - The Globe and Mail

Oct 04, 2024
pulisher
Oct 03, 2024

BriaCell Therapeutics’ (BCTX) Buy Rating Reaffirmed at HC Wainwright - Defense World

Oct 03, 2024
pulisher
Oct 03, 2024

Briacell stock Buy rating reaffirmed with clinical success in metastatic breast cancer trial - Investing.com

Oct 03, 2024
pulisher
Oct 02, 2024

BriaCell Therapeutics Announces Closing of $5 Million Offering - GlobeNewswire

Oct 02, 2024
pulisher
Oct 02, 2024

Daily Market Movement: BriaCell Therapeutics Corp (BCTX) Sees a -34.68 Decrease, Closing at 0.81 - The Dwinnex

Oct 02, 2024
pulisher
Oct 02, 2024

Bria-IMT Plus Immunotherapy Shows Early Promise in Breast Cancer Brain Metastasis - OncLive

Oct 02, 2024
pulisher
Oct 02, 2024

BriaCell Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient with “Eye-Bulging” Tumor - BioSpace

Oct 02, 2024
pulisher
Oct 01, 2024

BriaCell sets price for $5 million share and warrant offering - Investing.com

Oct 01, 2024
pulisher
Oct 01, 2024

BriaCell sets price for $5 million share and warrant offering By Investing.com - Investing.com Canada

Oct 01, 2024
pulisher
Oct 01, 2024

BriaCell Therapeutics Launches $5 Million Offering - TipRanks

Oct 01, 2024
pulisher
Oct 01, 2024

BriaCell Therapeutics Announces $5 Million Offering - GlobeNewswire

Oct 01, 2024
pulisher
Oct 01, 2024

BriaCell stock dips on data for breast cancer drug (NASDAQ:BCTX) - Seeking Alpha

Oct 01, 2024
pulisher
Oct 01, 2024

Briacell Reports 100% Resolution Of Brain Metastasis In Breast Cancer Patient With “Eye-Bulging” Tumor - MENAFN.COM

Oct 01, 2024
pulisher
Oct 01, 2024

BriaCell Therapeutics Corp. Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient with "Eye-Bulging" Tumor - Marketscreener.com

Oct 01, 2024
pulisher
Oct 01, 2024

There is no way BriaCell Therapeutics Corp (BCTX) can keep these numbers up - SETE News

Oct 01, 2024
pulisher
Oct 01, 2024

BriaCell Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient with 'Eye-Bulging” Tumor - The Manila Times

Oct 01, 2024
pulisher
Sep 30, 2024

Understanding the Risks of Investing in BriaCell Therapeutics Corp (BCTX) - Knox Daily

Sep 30, 2024
pulisher
Sep 30, 2024

A closer look at BCTX’s price-to-free cash flow ratio - US Post News

Sep 30, 2024
pulisher
Sep 30, 2024

BriaCell Therapeutics Corp’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - The InvestChronicle

Sep 30, 2024
pulisher
Sep 27, 2024

What Makes BRIACELL THERAP (BCTX) a New Strong Buy Stock - Yahoo Finance

Sep 27, 2024
pulisher
Sep 26, 2024

BriaCell Therapeutics Corp [BCTX] stock Initiated by H.C. Wainwright analyst, price target now $25 - The DBT News

Sep 26, 2024
pulisher
Sep 25, 2024

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Sees Significant Decline in Short Interest - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

BriaCell Therapeutics Corp. (NASDAQ:BCTX) Sees Large Increase in Short Interest - Defense World

Sep 25, 2024
pulisher
Sep 24, 2024

A new trading data show BriaCell Therapeutics Corp (BCTX) is showing positive returns. - SETE News

Sep 24, 2024
pulisher
Sep 23, 2024

BriaCell Therapeutics Corp’s latest rating changes from various analysts - Knox Daily

Sep 23, 2024
pulisher
Sep 23, 2024

Research Analysts Offer Predictions for BriaCell Therapeutics Corp.’s FY2024 Earnings (NASDAQ:BCTX) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Brokers Set Expectations for BriaCell Therapeutics Corp.’s FY2024 Earnings (TSE:BCT) - Defense World

Sep 23, 2024
pulisher
Sep 20, 2024

HC Wainwright Weighs in on BriaCell Therapeutics Corp.’s FY2029 Earnings (TSE:BCT) - Defense World

Sep 20, 2024
pulisher
Sep 20, 2024

BriaCell Therapeutics target cut by H.C. Wainwright - Investing.com

Sep 20, 2024

Briacell Therapeutics Corp (BCTX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
자본화:     |  볼륨(24시간):